A groundbreaking study suggests that applying CBD-infused lotion to the skin may reduce the risk of damage from ultraviolet ...

The off-label use of cannabidiol (CBD) has outpaced investigation. We assessed the effects of CBD in Angelman syndrome model mice lacking the Ube3a gene and found that chronic injection of CBD ...

Allen R. Voigt, founder and CEO of EndoPure Life Sciences, believes that trust has become the defining issue for the next ...

How can cannabis be used to fight acne and other skin inflammation? This is what a recent study published in the journal ...

Melatonin – a go-to sleep aid for kids and adults alike – continues to create media buzz, with conflicting messages that leave people uncertain about its safety. Some headlines point to melatonin’s ...

Avecho shares today entered trading halt, pending the release of results for the company's synthetic cannabinoid phase III ...

As president and CEO of D.A.R.E. America, I have spent my career working to keep our youth safe from dangerous substances ...

A new report reveals that both cannabis employment and revenue have dropped for the first time since legal adult-use cannabis ...

UK-based Ananda Pharma has announced successful completion of its Phase 1 pharmacokinetic study of its MRX1 cannabidiol oral solution to treat chronic pain conditions, with all study objectives met.

Cannabidiol (CBD) is a naturally occurring compound found in cannabis, thought to have beneficial effects on things like ...

Ananda Pharma Limited is a UK pharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions.